
HCA Healthcare, Inc. statistics
$499.05−0.32%Close 13 Nov 2026 · Market value $107.0B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
HCA Healthcare, Inc. is valued at $107.0B on its latest close. Its price is 15.8 times its earnings.
| Market value | $107.0B |
|---|
| Enterprise value | $160.2B |
|---|
| Price / earnings | 15.80 |
|---|
| Price / sales | 1.36 |
|---|
| EV / EBITDA | 10.11 |
|---|
| EV / sales | 2.04 |
|---|
| Price / free cash flow | 17.92 |
|---|
| Price / free cash flow, own 5-year average | 15.58 |
|---|
| EV / EBIT | 13.09 |
|---|
| EV / free cash flow | 26.54 |
|---|
| Free cash flow yield | 5.6% |
|---|
| Dividend yield | 0.6% |
|---|
Share price
| Latest close | $499.05 |
|---|
| Day's change | −0.3% |
|---|
| 52-week high | $556.52 |
|---|
| 52-week low | $353.99 |
|---|
| From 52-week high | −10.3% |
|---|
| Return · 1 month | +8.8% |
|---|
| Return · 3 months | +22.8% |
|---|
| Return · year to date | +6.9% |
|---|
| Return · 1 year | +5.4% |
|---|
| Beta · 1 year against the S&P 500 | 0.28 |
|---|
| 50-day average | $452.77 |
|---|
| 200-day average | $445.32 |
|---|
| RSI 14 | 61.2 |
|---|
| Average volume · 20 sessions | 1.4M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 15.9% |
|---|
| Net margin | 9.0% |
|---|
| Free cash flow margin | 10.2% |
|---|
| Return on assets | 15.8% |
|---|
| Return on invested capital | 19.4% |
|---|
| Return on invested capital, 5-year average | 19.4% |
|---|
| Return on capital employed | 27.1% |
|---|
| Stock-based compensation / revenue | 0.5% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $1.04B |
|---|
| Total debt | $48.70B |
|---|
| Net debt | $47.66B |
|---|
| Current ratio | 0.97 |
|---|
| Quick ratio | 0.63 |
|---|
| Net debt / EBITDA | 3.07 |
|---|
| Interest coverage | 5.34 |
|---|
Growth
| Revenue, latest quarter on a year | +3.6% |
|---|
| Revenue, twelve months on a year | +5.8% |
|---|
| EPS, latest quarter on a year | +4.5% |
|---|
| EPS, twelve months on a year | +17.0% |
|---|
| Revenue, 5-year compound | +8.0% |
|---|
| Revenue, 10-year compound | +6.7% |
|---|
| Net income, 5-year compound | +12.6% |
|---|
| Free cash flow, 5-year compound | +3.8% |
|---|
| EPS, 5-year compound | +21.0% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 239M |
|---|
| Shares outstanding, 5-year compound | −7.0% |
|---|
| Net share repurchases | $10.07B |
|---|
| Dividends per share | $2.88 |
|---|
| Dividend payout | 10.0% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $2.05B |
|---|
| Effective tax rate | 20.9% |
|---|
HCA in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.